Ligand Pharmaceuticals Incorporated
LGND
$193.03
-$2.07-1.06%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 171.21% | 17.29% | -18.45% | 16.63% | -3.21% |
| Total Receivables | 10.89% | -1.02% | 24.69% | -12.89% | 25.98% |
| Inventory | -23.17% | 5.99% | 3.54% | -15.69% | -10.35% |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -51.55% | 21.83% | 94.53% | -30.39% | -6.86% |
| Total Current Assets | 113.61% | 14.10% | -6.71% | 7.17% | -0.92% |
|
|
|||||
| Total Current Assets | 113.61% | 14.10% | -6.71% | 7.17% | -0.92% |
| Net Property, Plant & Equipment | -4.71% | 10.78% | -57.70% | -1.53% | -1.05% |
| Long-term Investments | 0.00% | 0.00% | -3.52% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | -3.52% | 0.00% | 0.00% |
| Total Other Intangibles | -6.64% | -3.20% | -3.10% | -3.00% | -2.92% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.95% | 3.10% | 6.01% | -10.74% | 78.59% |
| Total Assets | 55.68% | 4.77% | -3.86% | -1.37% | 10.21% |
|
|
|||||
| Total Accounts Payable | -57.14% | 59.97% | 2.54% | 11.48% | 161.80% |
| Total Accrued Expenses | 37.25% | -28.70% | -17.11% | 93.07% | 35.01% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -2.16% | 26.05% | -31.55% | 18.35% | -6.68% |
| Total Finance Division Other Current Liabilities | -87.32% | 27.74% | 518.06% | -12.23% | -0.77% |
| Total Other Current Liabilities | -87.32% | 27.74% | 518.06% | -12.23% | -0.77% |
| Total Current Liabilities | -52.82% | 10.31% | 58.12% | 49.81% | 33.43% |
|
|
|||||
| Total Current Liabilities | -52.82% | 10.31% | 58.12% | 49.81% | 33.43% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -4.62% | 29.85% | -39.21% | -6.43% | -2.31% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -8.99% | 6.42% | -30.29% | -17.29% | 24.80% |
| Total Liabilities | 338.56% | 9.26% | -1.29% | -2.07% | 24.65% |
|
|
|||||
| Common Stock & APIC | 1.11% | 5.31% | 0.94% | 9.06% | 29.50% |
| Retained Earnings | 25.32% | 1.06% | -8.51% | -5.86% | -1.33% |
| Treasury Stock & Other | 9.75% | 643.44% | 73.70% | -440.32% | 286.74% |
| Total Common Equity | 14.68% | 4.15% | -4.20% | -1.28% | 8.51% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 14.68% | 4.15% | -4.20% | -1.28% | 8.51% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 14.68% | 4.15% | -4.20% | -1.28% | 8.51% |
|
|
|||||